Pharmacovigilance: how medicine safety is monitored

What pharmacovigilance is

Pharmacovigilance is the ongoing process of monitoring, detecting, understanding and preventing harmful effects of medicines. Its name comes from words meaning drug and keeping watch, which captures the idea well: it is a continuous watch kept over medicines throughout the time they are used. No medicine is completely without risk; the aim is to make sure the benefits of a medicine continue to outweigh its risks for the people using it. Before approval, a medicine is tested in clinical trials, but these involve a limited number of people, often for a limited time, and under controlled conditions. They cannot reliably detect side effects that are rare, that only appear after long use, or that affect particular groups such as older people, children or those taking several medicines. Pharmacovigilance fills this gap by keeping watch once a medicine is in widespread everyday use.

Why it matters after a medicine is approved

When a medicine moves from trials into real-world use by large numbers of people, it is used by a much wider and more varied population than was studied, including people with other illnesses, those on multiple medicines, and different age groups. This is when rare side effects, unexpected interactions or problems that take time to appear can first become visible. History includes examples where serious effects only came to light after a medicine was widely used, which is exactly why continued monitoring is so important. Pharmacovigilance allows regulators to build a fuller picture of a medicine's safety over time, to compare its benefits and risks as new information arrives, and to take action if needed. This ongoing vigilance is a core part of keeping patients safe and maintaining public trust in medicines, and it applies to vaccines and medical devices as well as ordinary tablets.

How safety is monitored in the UK

In the UK, the Medicines and Healthcare products Regulatory Agency, the MHRA, is responsible for monitoring the safety of medicines and vaccines. A central tool is the Yellow Card scheme, through which patients, carers and healthcare professionals can report suspected side effects, known as adverse reactions, from medicines, vaccines and some medical devices. These reports are collected and analysed to look for patterns or signals that might indicate a previously unknown or more common problem. The MHRA also draws on other sources, including information from drug companies, who are legally required to monitor and report safety data, from research studies, from health records, and from safety systems in other countries. Specialist committees of independent experts review the evidence. Together this creates a network of watchfulness that can pick up concerns from many directions and bring them together for careful assessment.

What happens when a safety concern is found

When monitoring flags a possible safety concern, it is investigated carefully rather than acted on hastily, because a single report does not prove a medicine caused a problem. Experts weigh up how strong and consistent the evidence is, how serious the effect might be, and how it compares with the medicine's benefits. If a genuine concern is confirmed, a range of actions is possible depending on how serious it is. These can include updating the information leaflet and prescribing guidance to warn about a side effect, adding new precautions or restrictions on who should use the medicine or how, sending safety alerts to healthcare professionals, and, in the most serious cases, suspending or withdrawing a medicine from use. The aim is always proportionate action that protects patients while not needlessly denying people a medicine that helps them. Decisions are kept under review as further evidence emerges.

How you can help

Everyone has a part to play in keeping medicines safe. If you think you have had a side effect from a medicine, vaccine or medical device, you can report it yourself through the Yellow Card scheme, online or via its app, as well as telling your doctor, nurse or pharmacist; you do not have to be certain the medicine was to blame, as reporting suspicions helps build the picture. It is especially valuable to report side effects from newer medicines, which are marked with a black triangle symbol to show they are being monitored particularly closely. Beyond reporting, reading the patient information leaflet, taking medicines as directed, telling healthcare staff about all the medicines and supplements you take, and asking questions if you are unsure all support safe use. By reporting suspected reactions, patients and professionals directly contribute to a system that protects everyone.